Organization
Akari Therapeutics
4 clinical trials
Clinical trial
Multicentre Study of Nomacopan (rVA576) in Paediatric Haematopoietic Stem-Cell Transplant Associated Thrombotic MicroangiopathyStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
CONSENT II: Coversin in Paroxysmal Nocturnal Hemoglobinuria (PNH) in Patients With Resistance to Eculizumab Due to Complement C5 PolymorphismsStatus: , Estimated PCD: 2024-06-01
Clinical trial
A Randomized, Part A Partial Blinded and Part B Double Blinded, Placebo-controlled 24-week Clinical Study to Evaluate the Efficacy and Safety of Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)Status: Withdrawn, Estimated PCD: 2022-08-01
Clinical trial
Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH) in Patients With Resistance to Eculizumab Due to Complement C5 PolymorphismsStatus: Completed, Estimated PCD: 2018-03-20